Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Energy Industry News Wood secures contracts with Beach Energy and MEPAU for emissions reduction in Australia Wood has entered into contracts with Beach Energy and Mitsui E&P Australia (MEPAU) to create solutions that align… byPallavi MadhirajuAugust 1, 2023